These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1490825)

  • 21. Regulation of cytochrome P4501A1 in teleosts: sustained induction of CYP1A1 mRNA, protein, and catalytic activity by 2,3,7,8-tetrachlorodibenzofuran in the marine fish Stenotomus chrysops.
    Hahn ME; Stegeman JJ
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):187-98. PubMed ID: 8048062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis.
    Foster JR; Idle JR; Hardwick JP; Bars R; Scott P; Braganza JM
    J Pathol; 1993 Apr; 169(4):457-63. PubMed ID: 8501544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omeprazole weakly inhibits CYP1A2 activity in man.
    Rost KL; Fuhr U; Thomsen T; Zaigler M; Brockmöller J; Bohnemeier H; Roots I
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):567-74. PubMed ID: 10584979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of cytochrome P450IA genes (CYP1A) by omeprazole in the human alimentary tract.
    McDonnell WM; Scheiman JM; Traber PG
    Gastroenterology; 1992 Nov; 103(5):1509-16. PubMed ID: 1426869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human cytochrome P450 isoforms. Their genetic heterogeneity and induction by omeprazole.
    Farrell GC; Murray M
    Gastroenterology; 1990 Sep; 99(3):885-9. PubMed ID: 2199294
    [No Abstract]   [Full Text] [Related]  

  • 26. Dose-dependent up-regulation of rat pulmonary, renal, and hepatic cytochrome P-450 (CYP) 1A expression by nicotine feeding.
    Iba MM; Fung J; Pak YW; Thomas PE; Fisher H; Sekowski A; Halladay AK; Wagner GC
    Drug Metab Dispos; 1999 Sep; 27(9):977-82. PubMed ID: 10460794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omeprazole, cytochrome P450, and chemical carcinogenesis.
    Lucier GW; Thompson CL; Hoel DG
    Gastroenterology; 1992 May; 102(5):1823-4. PubMed ID: 1314754
    [No Abstract]   [Full Text] [Related]  

  • 28. P450/losec.
    Moldéus P; Berlin RG; Lu A; Castagnoli N; Carlsson E; Andersson T
    Gastroenterology; 1991 May; 100(5 Pt 1):1488-9. PubMed ID: 2013402
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug interactions: Part I.
    Gibaldi M
    Ann Pharmacother; 1992 May; 26(5):709-13. PubMed ID: 1591436
    [No Abstract]   [Full Text] [Related]  

  • 30. 4-Aminobiphenyl-hemoglobin adduct formation as an index of in vivo N-oxidation by hepatic cytochrome P-450IA2.
    Hammons GJ; Dooley KL; Kadlubar FF
    Chem Res Toxicol; 1991; 4(2):144-7. PubMed ID: 1782342
    [No Abstract]   [Full Text] [Related]  

  • 31. Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking.
    Kalow W; Tang BK
    Clin Pharmacol Ther; 1991 Jan; 49(1):44-8. PubMed ID: 1988240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omeprazole and the induction of human cytochrome P-450: a response to concerns about potential adverse effects.
    Parkinson A; Hurwitz A
    Gastroenterology; 1991 Apr; 100(4):1157-64. PubMed ID: 2001824
    [No Abstract]   [Full Text] [Related]  

  • 33. Omeprazole and hepatic monooxygenase.
    Golor J; Neubert D; Krüger N; Helge H
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1443-4. PubMed ID: 1551562
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical significance of the cytochrome P450 2C19 genetic polymorphism.
    Desta Z; Zhao X; Shin JG; Flockhart DA
    Clin Pharmacokinet; 2002; 41(12):913-58. PubMed ID: 12222994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific and dose-dependent enzyme induction by omeprazole in human beings.
    Rost KL; Brösicke H; Heinemeyer G; Roots I
    Hepatology; 1994 Nov; 20(5):1204-12. PubMed ID: 7927253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin.
    Rost KL; Brösicke H; Brockmöller J; Scheffler M; Helge H; Roots I
    Clin Pharmacol Ther; 1992 Aug; 52(2):170-80. PubMed ID: 1505152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P450IA2 and omeprazole.
    Farrell G
    Gastroenterology; 1992 May; 102(5):1822-3. PubMed ID: 1345326
    [No Abstract]   [Full Text] [Related]  

  • 38. [Omeprazole and the cytochrome P450 system of the liver].
    Petersen KU
    Leber Magen Darm; 1993 Sep; 23(5):186-92. PubMed ID: 8412467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose dependent induction of CYP1A2 activity by omeprazole (Antra).
    Rost KL; Brösicke H; Scheffler M; Roots I
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):542-3. PubMed ID: 1490825
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.